United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “United States Wound Care Management Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Wound Care Management market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags, Oxygen Therapy Devices, Pressure Relief Devices, Surgical Sutures, Tissue Engineered – Skin Substitutes, Traditional Wound Management, Wound Closure Devices and Wound Debridement Devices.

The United States Wound Care Management Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Wound Care Management Market.
• Global corporate-level profiles of key companies operating within the United States Wound Care Management Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Wound Care Management is segmented as follows:

• Advanced Wound Management

• Compression Therapy

• Negative Pressure Wound Therapy (NPWT)

• Ostomy Drainage Bags

• Oxygen Therapy Devices

• Pressure Relief Devices

• Surgical Sutures

• Tissue Engineered – Skin Substitutes

• Traditional Wound Management

• Wound Closure Devices

• Wound Debridement Devices

Reasons to Buy

Key Reasons to Purchase – The United States Wound Care Management Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Wound Care Management Market Outlook to 2025” report:
• Acelity Holdings, Inc. (Inactive)
• Smith & Nephew Plc
• Cardinal Health Inc

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 16

1.2 List of Figures 22

2 Introduction 25

2.1 What Is This Report About? 25

2.2 Wound Care Management Market Segmentation 25

2.3 Definitions of Markets Covered in the Report 29

3 Wound Care Management Market, United States 45

3.1 Wound Care Management Market, United States, Revenue ($m), 2015-2025 45

3.2 Wound Care Management Market, United States, Revenue Mix ($m), 2019 47

3.3 Wound Care Management Market, United States, Category Contribution by Revenue ($m), 2019 48

3.4 Wound Care Management Market, United States, Revenue ($m), 2015-2025 50

3.5 Wound Care Management Market, United States, Volume (Units), 2015-2025 53

3.6 Wound Care Management Market, United States, Volume (Units), 2015-2025 55

3.7 Wound Care Management Market, United States, Company Share by Revenue ($m), 2019 58

4 Advanced Wound Management Market, United States 60

4.1 Advanced Wound Management Market, United States, Revenue Mix ($m), 2019 60

4.2 Advanced Wound Management Market, United States, Segment Contribution (%), 2019 61

4.3 Advanced Wound Management Market, United States, Revenue ($m), 2015-2025 63

4.3.1 Alginates Market, United States, Revenue ($m), by Segment, 2015-2025 66

4.3.2 Collagens Market, United States, Revenue ($m), by Segment, 2015-2025 68

4.3.3 Foams Market, United States, Revenue ($m), by Segment, 2015-2025 70

4.3.4 Hydrocolloids Market, United States, Revenue ($m), by Segment, 2015-2025 72

4.3.5 Hydrofibres Market, United States, Revenue ($m), by Segment, 2015-2025 74

4.3.6 Hydrogels Market, United States, Revenue ($m), by Segment, 2015-2025 76

4.3.7 Semi-Permeable Films Market, United States, Revenue ($m), by Segment, 2015-2025 78

4.3.8 Superabsorbents Market, United States, Revenue ($m), by Segment, 2015-2025 80

4.3.9 Wound Contact Layers Market, United States, Revenue ($m), by Segment, 2015-2025 82

4.4 Advanced Wound Management Market, United States, Volume (Units), 2015-2025 84

4.4.1 Alginates Market, United States, Volume (Units), by Segment, 2015-2025 87

4.4.2 Collagens Market, United States, Volume (Units), by Segment, 2015-2025 89

4.4.3 Foams Market, United States, Volume (Units), by Segment, 2015-2025 91

4.4.4 Hydrocolloids Market, United States, Volume (Units), by Segment, 2015-2025 93

4.4.5 Hydrofibres Market, United States, Volume (Units), by Segment, 2015-2025 95

4.4.6 Hydrogels Market, United States, Volume (Units), by Segment, 2015-2025 97

4.4.7 Semi-Permeable Films Market, United States, Volume (Units), by Segment, 2015-2025 99

4.4.8 Superabsorbents Market, United States, Volume (Units), by Segment, 2015-2025 101

4.4.9 Wound Contact Layers Market, United States, Volume (Units), by Segment, 2015-2025 103

4.5 Advanced Wound Management Market, United States, Average Price ($) , 2015-2025 105

4.6 Advanced Wound Management Market, United States, Distribution Share by Revenue ($m), 2019 109

4.7 Advanced Wound Management Market, United States, Company Share by Revenue ($m), 2019 110

5 Compression Therapy Market, United States 113

5.1 Compression Therapy Market, United States, Revenue Mix ($m), 2019 113

5.2 Compression Therapy Market, United States, Segment Contribution (%), 2019 114

5.3 Compression Therapy Market, United States, Revenue ($m), 2015-2025 115

5.3.1 Pneumatic Compression Therapy Market, United States, Revenue ($m), by Segment, 2015-2025 117

5.3.2 Static Compression Therapy Market, United States, Revenue ($m), by Segment, 2015-2025 119

5.4 Compression Therapy Market, United States, Volume (Units), 2015-2025 121

5.4.1 Pneumatic Compression Therapy Market, United States, Volume (Units), by Segment, 2015-2025 123

5.4.2 Static Compression Therapy Market, United States, Volume (Units), by Segment, 2015-2025 125

5.5 Compression Therapy Market, United States, Average Price ($), 2015-2025 127

5.6 Compression Therapy Market, United States, Distribution Share by Revenue ($m), 2019 129

5.7 Compression Therapy Market, United States, Company Share by Revenue ($m), 2019 130

6 Negative Pressure Wound Therapy (NPWT) Market, United States 132

6.1 Negative Pressure Wound Therapy (NPWT) Market, United States, Revenue ($m), 2015-2025 132

6.1.1 NPWT Devices & Accessories Market, United States, Revenue ($m), by Segment, 2015-2025 134

6.2 Negative Pressure Wound Therapy (NPWT) Market, United States, Volume (Units), 2015-2025 136

6.2.1 NPWT Devices & Accessories Market, United States, Volume (Units), by Segment, 2015-2025 138

6.3 Negative Pressure Wound Therapy (NPWT) Market, United States, Average Price ($), 2015-2025 140

6.4 Negative Pressure Wound Therapy (NPWT) Market, United States, Distribution Share by Revenue ($m), 2019 141

6.5 Negative Pressure Wound Therapy (NPWT) Market, United States, Company Share by Revenue ($m), 2019 142

7 Ostomy Drainage Bags Market, United States 144

7.1 Ostomy Drainage Bags Market, United States, Revenue Mix ($m), 2019 144

7.2 Ostomy Drainage Bags Market, United States, Segment Contribution (%), 2019 145

7.3 Ostomy Drainage Bags Market, United States, Revenue ($m), 2015-2025 146

7.3.1 Colostomy Market, United States, Revenue ($m), by Segment, 2015-2025 148

7.3.2 Ileostomy Market, United States, Revenue ($m), by Segment, 2015-2025 150

7.3.3 Urostomy Market, United States, Revenue ($m), by Segment, 2015-2025 152

7.4 Ostomy Drainage Bags Market, United States, Volume (Units), 2015-2025 154

7.4.1 Colostomy Market, United States, Volume (Units), by Segment, 2015-2025 156

7.4.2 Ileostomy Market, United States, Volume (Units), by Segment, 2015-2025 158

7.4.3 Urostomy Market, United States, Volume (Units), by Segment, 2015-2025 160

7.5 Ostomy Drainage Bags Market, United States, Average Price ($), 2015-2025 162

7.6 Ostomy Drainage Bags Market, United States, Distribution Share by Revenue ($m), 2019 164

7.7 Ostomy Drainage Bags Market, United States, Company Share by Revenue ($m), 2019 165

8 Oxygen Therapy Devices Market, United States 166

8.1 Oxygen Therapy Devices Market, United States, Revenue ($m), 2015-2025 166

8.1.1 Hyperbaric Oxygen Chambers Market, United States, Revenue ($m), by Segment, 2015-2025 168

8.2 Oxygen Therapy Devices Market, United States, Volume (Units), 2015-2025 170

8.2.1 Hyperbaric Oxygen Chambers Market, United States, Volume (Units), by Segment, 2015-2025 172

8.3 Oxygen Therapy Devices Market, United States, Average Price ($) , 2015-2025 174

8.4 Oxygen Therapy Devices Market, United States, Distribution Share by Revenue ($m), 2019 175

8.5 Oxygen Therapy Devices Market, United States, Company Share by Revenue ($m), 2019 176

9 Pressure Relief Devices Market, United States 178

9.1 Pressure Relief Devices Market, United States, Revenue Mix ($m), 2019 178

9.2 Pressure Relief Devices Market, United States, Segment Contribution (%), 2019 179

9.3 Pressure Relief Devices Market, United States, Revenue ($m), 2015-2025 180

9.3.1 Mattress Overlays Market, United States, Revenue ($m), by Segment, 2015-2025 182

9.3.2 Mattresses Market, United States, Revenue ($m), by Segment, 2015-2025 184

9.4 Pressure Relief Devices Market, United States, Volume (Units), 2015-2025 186

9.4.1 Mattress Overlays Market, United States, Volume (Units), by Segment, 2015-2025 188

9.4.2 Mattresses Market, United States, Volume (Units), by Segment, 2015-2025 190

9.5 Pressure Relief Devices Market, United States, Average Price ($), 2015-2025 192

9.6 Pressure Relief Devices Market, United States, Distribution Share by Revenue ($m), 2019 194

9.7 Pressure Relief Devices Market, United States, Company Share by Revenue ($m), 2019 195

10 Surgical Sutures Market, United States 197

10.1 Surgical Sutures Market, United States, Revenue Mix ($m), 2019 197

10.2 Surgical Sutures Market, United States, Segment Contribution (%), 2019 198

10.3 Surgical Sutures Market, United States, Revenue ($m), 2015-2025 199

10.3.1 Automated Suturing Devices Market, United States, Revenue ($m), by Segment, 2015-2025 201

10.3.2 Sutures Market, United States, Revenue ($m), by Segment, 2015-2025 203

10.4 Surgical Sutures Market, United States, Volume (Units), 2015-2025 205

10.4.1 Automated Suturing Devices Market, United States, Volume (Units), by Segment, 2015-2025 207

10.4.2 Sutures Market, United States, Volume (Units), by Segment, 2015-2025 209

10.5 Surgical Sutures Market, United States, Average Price ($) , 2015-2025 211

10.6 Surgical Sutures Market, United States, Distribution Share by Revenue ($m), 2019 212

10.7 Surgical Sutures Market, United States, Company Share by Revenue ($m), 2019 213

11 Tissue Engineered – Skin Substitutes Market, United States 215

11.1 Tissue Engineered – Skin Substitutes Market, United States, Revenue Mix ($m), 2019 215

11.2 Tissue Engineered – Skin Substitutes Market, United States, Segment Contribution (%), 2019 216

11.3 Tissue Engineered – Skin Substitutes Market, United States, Revenue ($m), 2015-2025 217

11.3.1 Acellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 219

11.3.2 Cellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 221

11.4 Tissue Engineered – Skin Substitutes Market, United States, Volume (Units), 2015-2025 223

11.4.1 Acellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 225

11.4.2 Cellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 227

11.5 Tissue Engineered – Skin Substitutes Market, United States, Average Price ($), 2015-2025 229

11.6 Tissue Engineered – Skin Substitutes Market, United States, Distribution Share by Revenue ($m), 2019 230

11.7 Tissue Engineered – Skin Substitutes Market, United States, Company Share by Revenue ($m), 2019 231

12 Traditional Wound Management Market, United States 233

12.1 Traditional Wound Management Market, United States, Revenue Mix ($m), 2019 233

12.2 Traditional Wound Management Market, United States, Segment Contribution (%), 2019 234

12.3 Traditional Wound Management Market, United States, Revenue ($m), 2015-2025 235

12.3.1 Abdominal Pads (ABD) Market, United States, Revenue ($m), by Segment, 2015-2025 238

12.3.2 Bandages Market, United States, Revenue ($m), by Segment, 2015-2025 240

12.3.3 Gauze Sponges Market, United States, Revenue ($m), by Segment, 2015-2025 242

12.3.4 Gauzes Market, United States, Revenue ($m), by Segment, 2015-2025 244

12.3.5 Sponges Market, United States, Revenue ($m), by Segment, 2015-2025 246

12.4 Traditional Wound Management Market, United States, Volume (Units), 2015-2025 248

12.4.1 Abdominal Pads (ABD) Market, United States, Volume (Units), by Segment, 2015-2025 251

12.4.2 Bandages Market, United States, Volume (Units), by Segment, 2015-2025 253

12.4.3 Gauze Sponges Market, United States, Volume (Units), by Segment, 2015-2025 255

12.4.4 Gauzes Market, United States, Volume (Units), by Segment, 2015-2025 257

12.4.5 Sponges Market, United States, Volume (Units), by Segment, 2015-2025 259

12.5 Traditional Wound Management Market, United States, Average Price ($), 2015-2025 261

12.6 Traditional Wound Management Market, United States, Distribution Share by Revenue ($m), 2019 263

12.7 Traditional Wound Management Market, United States, Company Share by Revenue ($m), 2019 264

13 Wound Closure Devices Market, United States 266

13.1 Wound Closure Devices Market, United States, Revenue Mix ($m), 2019 266

13.2 Wound Closure Devices Market, United States, Segment Contribution (%), 2019 267

13.3 Wound Closure Devices Market, United States, Revenue ($m), 2015-2025 268

13.3.1 Ligating Clips Market, United States, Revenue ($m), by Segment, 2015-2025 271

13.3.2 Surgical Adhesion Barriers Market, United States, Revenue ($m), by Segment, 2015-2025 273

13.3.3 Tissue Adhesives Market, United States, Revenue ($m), by Segment, 2015-2025 275

13.3.4 Tissue Sealants Market, United States, Revenue ($m), by Segment, 2015-2025 277

13.3.5 Topical Absorbable Hemostats Market, United States, Revenue ($m), by Segment, 2015-2025 279

13.4 Wound Closure Devices Market, United States, Volume (Units), 2015-2025 282

13.4.1 Ligating Clips Market, United States, Volume (Units), by Segment, 2015-2025 285

13.4.2 Surgical Adhesion Barriers Market, United States, Volume (Units), by Segment, 2015-2025 287

13.4.3 Tissue Adhesives Market, United States, Volume (Units), by Segment, 2015-2025 289

13.4.4 Tissue Sealants Market, United States, Volume (Units), by Segment, 2015-2025 291

13.4.5 Topical Absorbable Hemostats Market, United States, Volume (Units), by Segment, 2015-2025 293

13.5 Wound Closure Devices Market, United States, Average Price ($) , 2015-2025 296

13.6 Wound Closure Devices Market, United States, Distribution Share by Revenue ($m), 2019 299

13.7 Wound Closure Devices Market, United States, Company Share by Revenue ($m), 2019 300

14 Wound Debridement Devices Market, United States 302

14.1 Wound Debridement Devices Market, United States, Revenue Mix ($m), 2019 302

14.2 Wound Debridement Devices Market, United States, Segment Contribution (%), 2019 303

14.3 Wound Debridement Devices Market, United States, Revenue ($m), 2015-2025 304

14.4 Wound Debridement Devices Market, United States, Volume (Units), 2015-2025 306

14.5 Wound Debridement Devices Market, United States, Average Price ($) , 2015-2025 308

14.6 Wound Debridement Devices Market, United States, Distribution Share by Revenue ($m), 2019 309

14.7 Wound Debridement Devices Market, United States, Company Share by Revenue ($m), 2019 310

15 Overview of Key Companies in United States, Wound Care Management Market 312

15.1 Acelity Holdings, Inc. (Inactive) 312

15.1.1 Company Overview 312

15.2 Smith & Nephew Plc 312

15.2.1 Company Overview 312

15.3 Cardinal Health Inc 312

15.3.1 Company Overview 312

15.4 Hollister Inc 312

15.4.1 Company Overview 312

15.5 Allergan Ltd 313

15.5.1 Company Overview 313

15.6 Hill-Rom Holdings Inc 313

15.6.1 Company Overview 313

15.7 Ethicon Inc 313

15.7.1 Company Overview 313

15.8 Medline Industries Inc 313

15.8.1 Company Overview 313

15.9 BSN medical GmbH 314

15.9.1 Company Overview 314

15.10 Molnlycke Health Care AB 314

15.10.1 Company Overview 314

15.11 ConvaTec Group Plc 314

15.11.1 Company Overview 314

15.12 Coloplast A/S 314

15.12.1 Company Overview 314

15.13 Derma Sciences Inc 315

15.13.1 Company Overview 315

15.14 CR Bard Inc 315

15.14.1 Company Overview 315

15.15 Organogenesis Inc 315

15.15.1 Company Overview 315

15.16 3M Co 315

15.16.1 Company Overview 315

15.17 Stryker Corp 316

15.17.1 Company Overview 316

15.18 Medtronic Plc 316

15.18.1 Company Overview 316

15.19 Integra LifeSciences Corp 316

15.19.1 Company Overview 316

15.20 ArjoHuntleigh AB 316

15.20.1 Company Overview 316

15.21 B. Braun Melsungen AG 317

15.21.1 Company Overview 317

15.22 Paul Hartmann AG 317

15.22.1 Company Overview 317

15.23 MiMedx Group Inc 317

15.23.1 Company Overview 317

15.24 Baxter International Inc 317

15.24.1 Company Overview 317

16 Wound Care Management Market Pipeline Products 318

17 Financial Deals Landscape 319

17.1 Acquisition 319

17.1.1 Safeguard Medical Acquires Water-Jel Technologies 319

17.1.2 Conventus Orthopaedics Acquires Flower Orthopedics 320

17.1.3 Conatus Pharma Acquires Histogen 321

17.1.4 Vivo Capital May Sell Surgical Specialties for USD500 Million 323

17.1.5 Amneal Pharma to Acquire

65.1% Stake in AvKARE 324

17.1.6 Novartis Acquires The Medicines Co 326

17.1.7 Dare Bioscience Acquires Microchips Biotech 329

17.1.8 Marmon Acquires 60% Stake in Colson Medical Companies from Colson Associates 331

17.1.9 Generex Biotech Acquires Additional 38% Stake in Olaregen Therapeutix 333

17.1.10 AtriCure to Acquire SentreHEART 334

17.1.11 Stedical Scientific Acquires PermeaDerm 336

17.2 Asset Transactions 337

17.2.1 SANUWAVE Health to Acquire UltraMIST and Exclusive Partnership Rights for Wound Care Biologic Products from Celularity 337

17.2.2 Mitsubishi Chemical Performance Polymers Acquires Assets from AdvanSource Biomaterials for USD7.3 Million 339

17.3 Debt Offerings 341

17.3.1 CryoLife Prices Private Placement of

4.250% Notes Due 2025 for USD100 Million 341

17.3.2 Arch Therapeutics Raises USD0.55 Million in Private Placement of Convertible Note 343

17.3.3 Stryker Raises USD650 Million in Public Offering of

1.15% Notes Due 2025 344

17.3.4 Stryker Raises USD1 Billion in Public Offering of

1.95% Notes Due 2030 346

17.3.5 Stryker Raises USD650 Million in Public Offering of

2.9% Notes Due 2050 348

17.3.6 Baxter International Raises USD500 Million in Private Placement of

3.95% Senior Notes Due 2030 350

17.3.7 Baxter International Raises USD750 Million in Private Placement of

3.75% Senior Notes Due 2025 351

17.3.8 Collegium Pharma Raises USD143.8 Million in Public Offering of

2.625% Notes Due 2026 352

17.3.9 Integra LifeSciences Prices Private Placement of

0.5% Convertible Senior Notes Due 2025 for USD500 Million 354

17.3.10 KitoTech Medical Raises USD1.5 Million in Private Placement of Bonds 356

17.3.11 Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031 357

17.3.12 Stryker Raises USD881.3 Million in Public Offering of

0.75% Notes Due 2029 359

17.3.13 Stryker Raises USD936.4 Million in Public Offering of

0.25% Notes Due 2024 361

17.3.14 Hill-Rom (Hillrom) to Raise USD425 Million in Private Placement of Notes 363

17.3.15 SweetBio Raises USD0.80 Million in Debt Offering 364

17.4 Equity Offerings 365

17.4.1 ACell to Raise up to USD80 Million in IPO of Shares 365

17.4.2 Innovation Pharma Files Registration Statement for Public Offering of Securities up to USD60 Million 367

17.4.3 Tenax Therapeutics to Raise USD8 Million in Private Placement of Shares 368

17.4.4 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 370

17.4.5 Avita Medical to Raise Funds in Public Offering of Shares 372

17.4.6 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 373

17.4.7 Arch Therapeutics to Raise USD0.85 Million in Private Placement upon Exercise of Warrants 374

17.4.8 ThermoGenesis to Raise USD15 Million in Public Offering of Common Stock 375

17.4.9 Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD75 Million 377

17.4.10 Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD25 Million 379

17.4.11 NovaBay Pharma to Raise USD4.3 Million in Public Offering of Shares 381

17.4.12 ThermoGenesis Holdings Raises USD3.5 Million in Registered Direct Offering 383

17.4.13 Collegium Pharma Plans to Raise up to USD15.6 Million in Public Offering of Shares 384

17.4.14 Harpoon Therapeutics Files Registration Statement for Public Offering of Securities for up to USD250 Million 385

17.4.15 Harpoon Therapeutics Plans to Raise USD75 Million in Public Offering of Shares 386

17.4.16 Tenax Therapeutics Prices Private Placement of Shares and Warrants for USD2.8 Million 387

17.4.17 PolarityTE Prices Public Offering of Shares and Warrants for USD25 Million 388

17.4.18 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 390

17.4.19 Synedgen Raises USD2.6 Million in Financing 391

17.4.20 Sintx Technologies to Raise USD8.8 million in Rights Offering 392

17.4.21 Misonix Prices Public Offering of Shares for USD30 Million 394

17.4.22 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 396

17.4.23 Orgenesis to Raise USD9.2 Million in Private Placement of Shares and Warrants 398

17.4.24 Abeona Therapeutics Raises USD103.5 Million in Public Offering of Shares and Warrants 400

17.4.25 ThermoGenesis Files Registration Statement for Public Offering of Shares for up to USD30 Million 402

17.4.26 Sonoma Pharma Raises USD1.6 Million in Public Offering of Shares 403

17.4.27 Arch Therapeutics Plans to Raise Funds through Public Offering of Shares 404

17.4.28 Organogenesis Prices USD45 Million Public Offering of Shares 405

17.4.29 Avita Medical Raises USD15.4 Million in Private Placement of Shares 407

17.4.30 Collegium Pharma Plans to Raise up to USD300 Million in Public Offering of Securities 408

17.4.31 PolarityTE Plans to Raise up to USD21.8 Million in Public Offering of Shares 409

17.4.32 Arch Therapeutics Raises USD2.5 Million in Private Placement of Units 410

17.4.33 Sanara MedTech Raises USD10 Million in Private Placement of Shares 412

17.4.34 Drive DeVilbiss Healthcare Raises USD35 Million in Financing Round 413

17.4.35 BIOLIFE4D to Raise up to USD47.6 Million in Public Offering of Shares 414

17.4.36 Organogenesis Plans to Raise up to USD100 Million in Public Offering of Securities 415

17.4.37 NovaBay Pharma Raises USD4.2 Million in Registered Direct Offering of Shares 416

17.4.38 NovaBay Pharma Raises USD2.7 Million in Private Placement of Preferred Stock and Warrants 418

17.5 Grants 420

17.5.1 Novel Polymer Matrix for Dental Applications 420

17.6 Merger 421

17.6.1 Organovo Holdings Terminates Merger with Tarveda Therapeutics 421

17.6.2 Organovo Holdings Receives Merger Proposal from Viscient Biosciences 423

17.7 Partnerships 424

17.7.1 Rochal Industries Enters into Licensing Agreement with Sanara MedTech 424

17.7.2 BandGrip Enters into Agreement with Medline Industries 425

17.7.3 CryoLife Enters into Agreement with Misonix 426

17.7.4 Mayo Clinic and W. L. Gore & Associates Form Joint Venture 427

17.7.5 Avita Medical Enters into Licensing Agreement with University of Colorado Anschutz Medical Campus 428

17.7.6 Rochal Industries Enters into Licensing Agreement with Sanara MedTech 429

17.7.7 BioCardia Enters into Development Agreement with AstraZeneca 430

17.8 Private Equity 431

17.8.1 MiMedx to Raise USD100 Million in Private Equity Financing 431

17.8.2 Lattice Biologics to Raise USD4.24 Million in Private Placement of Shares 433

17.8.3 PolarityTE to Raise up to USD25 Million in Private Financing 434

17.8.4 Corre Partners and Legion Partners Invests USD100 Million in NN 436

17.8.5 BioRestorative Therapies to Raise USD5.4 Million in Private Financing 437

17.9 Venture Financing 438

17.9.1 Zurex Pharma Raises USD7.5 Million in Venture Financing 438

17.9.2 Imbed Biosciences Raises USD1.5 Million in Venture Financing 439

17.9.3 R2 Technologies Raises USD10 Million in Second Tranche of Series B Financing 440

17.9.4 Poly Group Raises USD0.1 Million in Venture Financing 441

17.9.5 Vaporox Raises USD1.5 Million in Financing 442

17.9.6 Biostage Raises USD2.18 Million in Venture Financing 443

17.9.7 Surgimatix to Raise USD1 Million in Venture Financing 444

17.9.8 Akeso Biomedical Raises USD0.6 Million in Venture Financing 445

17.9.9 Turn Therapeutics Raises Funds through Series B Financing 446

17.9.10 Carmell Therapeutics Raises USD0.1 Million in Venture Financing 447

17.9.11 Recovery Force Health Raises USD10 Million in Venture Financing 448

17.9.12 Gemstone Biotherapeutics Raises USD0.25 Million in Financing Round 449

17.9.13 Dezzio (GoRelax) Secures USD0.15 Million in Crowdfunding 450

17.9.14 Electrochemical Oxygen Concepts Raises USD2.3 Million in Venture Financing 451

17.9.15 Omeza Secures Additional USD1.25 Million in Venture Funding 452

17.9.16 Aatru Medical Raises Funds through Venture Financing 453

17.9.17 Nevoa Life Sciences Raises USD1.6 Million in Venture Financing 454

18 Recent Developments 455

18.1 Corporate Communications 455

18.1.1 Jul 09, 2020: Abeona Therapeutics announces appointment of Michael Amoroso as Chief Commercial Officer 455

18.1.2 Mar 23, 2020: McKesson announces executive vice president and chief strategy and business development officer to step down 455

18.1.3 Mar 02, 2020: Stryker announces new Investor Relations leader 456

18.1.4 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum 456

18.1.5 Feb 22, 2020: Amniox appoints new vice president of Sales 456

18.1.6 Feb 21, 2020: Tenax announces the addition of Mayo Clinic expert, Dr. Barry Borlaug, to Scientific Advisory Board 457

18.1.7 Feb 20, 2020: Agenus announces positive interim data from a study of AGEN1181 457

18.1.8 Feb 18, 2020: NN appoints Warren Veltman as president and CEO 458

18.1.9 Feb 16, 2020: CEO of Mako Medical announced the launch of new nutritional DNA test 458

18.1.10 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement 459

18.1.11 Feb 13, 2020: DERMALOG provides the world’s first biometric border control system with integrated fever detection 459

18.1.12 Feb 10, 2020: Chi-Med highlights updated phase II Savolitinib / Imfinzi combination data in advanced papillary renal cell carcinoma at 2020 ASCO Genitourinary Cancers Symposium 460

18.1.13 Feb 10, 2020: Collegium Pharmaceutical announces Proposed Convertible Senior Notes Offering 461

18.1.14 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan 462

18.1.15 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors 463

18.1.16 Jan 28, 2020: 3M Company: Departure of directors or certain officers 463

18.1.17 Jan 27, 2020: Yamaha Motor Ventures & Laboratory Silicon Valley leads seed funding round for Australian Health Technology Startup loop+ 464

18.1.18 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 464

18.1.19 Jan 20, 2020: Innovative Healthcare provider INLIV recruits industry veteran Lori Casselman to Scale Wello as President and Chief Revenue Officer 464

18.1.20 Jan 16, 2020: Audax Private Debt provides financing to support Olympus Partners Investment in Soliant Health 465

18.1.21 Jan 13, 2020: Orgenesis appoints industry veteran Mario Philips to its board of directors 465

18.1.22 Jan 08, 2020: BioCardia announces new U.S. patent covering CardiAMP cell therapy and issuance of two Asian patents covering Radial Artery approach for Cardiac Cell and Gene Therapy Delivery 465

18.1.23 Jan 08, 2020: Midatech Pharma: Positive results from MTD201-102 study support subcutaneous route for long-acting octreotide product 466

18.1.24 Jan 08, 2020: Anavex Life Sciences issued new U.S. patent for ANAVEX2-73 treatment of Neurodevelopmental Disorders including Rett Syndrome and Multiple Sclerosis 468

18.1.25 Jan 07, 2020: Abeona Therapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 468

18.1.26 Jan 02, 2020: ThermoGenesis Holdings announces board of directors and management changes 469

18.1.27 Dec 31, 2019: NN hires Christina Carroll and Tom Wilson to board of directors 469

18.1.28 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 470

18.1.29 Dec 20, 2019: Hill-Rom Holdings nominates Felicia Norwood to stand for election to its board of directors 470

18.1.30 Dec 20, 2019: Hill-Rom Holdings nominates Felicia Norwood to stand for election to its board of directors 471

18.1.31 Dec 19, 2019: World-Renowned Neurosurgeon selected to lead nationally-recognized Henry Ford Medical Group 471

18.1.32 Dec 19, 2019: Dynatronics welcomes new general counsel and senior director of sales operations 472

18.1.33 Dec 19, 2019: Innovation Pharmaceuticals: Departure of Directors or Certain Officers; Election of Directors 472

18.1.34 Dec 18, 2019: Owens & Minor names David Myers as SVP & Chief Procurement Officer 473

18.1.35 Dec 16, 2019: MiMedx Announces addition of Peter M. Carlson 473

18.1.36 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 473

18.1.37 Dec 09, 2019: Michael C. Riordan Elected to Owens & Minor board of directors 474

18.1.38 Dec 09, 2019: McKesson appoints Nancy Flores as executive vice president, chief information and chief technology officer 474

18.1.39 Dec 06, 2019: Gilero opens new design center in Southern California 475

18.1.40 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business 475

18.1.41 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors 475

18.1.42 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 476

18.1.43 Nov 27, 2019: Luna Innovations names Gene Nestro as Chief Financial Officer 477

18.1.44 Nov 26, 2019: Dr. Emanual Maverakis, recipient of presidential award for scientists and engineers, joins RenovaCare 477

18.1.45 Nov 26, 2019: MiMedx names William “Butch” Hulse as General Counsel and Secretary 478

18.1.46 Nov 18, 2019: RenovaCare appoints Alan L. Rubino as President and CEO 479

18.1.47 Nov 13, 2019: Bausch + Lomb And TerraCycle announce donation of new custom training modules incorporating used contact lens Materials to Guide Dog Foundation 480

18.1.48 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 481

18.1.49 Nov 06, 2019: Owens & Minor announces new organizational structure to better serve customers 481

18.1.50 Nov 05, 2019: Stereotaxis and inHEART combine robotic precision and advanced preoperative 3D mapping to treat cardiac arrhythmias 482

18.1.51 Nov 01, 2019: Orthofix appoints Jon Serbousek as President and Chief Executive Officer 483

18.1.52 Oct 31, 2019: Orgenesis appoints Bala S. Manian to its scientific advisory board 483

18.1.53 Oct 23, 2019: Arlington capital partners portfolio company Riverpoint Medical names Doug King as chief executive officer 484

18.1.54 Oct 18, 2019: McKesson’s Board of Directors appoints Maria Martinez as new independent Director 484

18.1.55 Oct 14, 2019: Anika appoints Mira Leiwant as vice president of regulatory affairs, quality, and clinical affairs 485

18.1.56 Oct 10, 2019: Atrium Health welcomes new Senior Vice President, Enterprise Strategy and Planning 485

18.1.57 Oct 10, 2019: Jefferson Hospital earns prestigious perinatal care certification from Joint Commission 486

18.1.58 Oct 08, 2019: BioDerm adds CFO and new board member to strengthen the management team and enhance growth prospects 487

18.1.59 Oct 07, 2019: Xtant Medical names Sean Browne President and Chief Executive Officer 487

18.1.60 Oct 01, 2019: Owens & Minor appoints Robert Henkel to its board of directors 488

18.1.61 Oct 01, 2019: Sonoma Pharmaceuticals announces Management Changes 488

18.1.62 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 489

18.1.63 Sep 24, 2019: Dr. Frank Gerberick, Procter & Gamble product safety veteran, joins RenovaCare 489

18.1.64 Sep 23, 2019: CONMED adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors 490

18.1.65 Sep 20, 2019: MiMedx announces resignation of board member 491

18.1.66 Sep 19, 2019: Vivex Biologics announces Peter Wehrly as the new CEO of the company 491

18.1.67 Sep 18, 2019: Invacare appoints Julie Beck to Board of Directors 491

18.1.68 Sep 16, 2019: NovaBay Pharmaceuticals names Finance Executive Jeff Zheng to its Board of Directors 492

18.1.69 Sep 16, 2019: BioRestorative Therapies scientific advisory board member and clinical director of regenerative disc/spine program, Dr. Wayne J. Olan, to receive prestigious award 492

18.1.70 Sep 13, 2019: FDA clears GE’s AI algorithms to identify pneumothorax 493

18.1.71 Sep 06, 2019: Cytokinetics to present on its Hypertrophic Cardiomyopathy drug candidate CK-274 at 23rd Annual HFSA Scientific Meeting 494

18.1.72 Sep 06, 2019: United Health Products appoints Dr. Gerard Abate Chief Medical Director 494

18.1.73 Sep 05, 2019: Mary Beth Vitale appointed to Luna Innovations board of directors 495

18.1.74 Sep 04, 2019: PolarityTE appoints Peter Cohen as Chairman of the Board 495

18.1.75 Sep 03, 2019: MemorialCare Long Beach Medical Center names Eric Ramos, M.D., FAAFP, as new Chief Medical Officer 496

18.1.76 Aug 28, 2019: Rose Kelly-Falls named global leader of procurement and supply chain for Cook Medical 496

18.1.77 Aug 28, 2019: Dynatronics promotes Brian Baker to Chief Executive Officer 497

18.1.78 Aug 26, 2019: GT Medical Technologies to be honored with an AZBio Fast Lane Award 497

18.1.79 Aug 26, 2019: PolarityTE: Changes in board 499

18.1.80 Aug 20, 2019: Dr. Robin Robinson, founding director of BARDA joins RenovaCare 499

18.1.81 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 500

18.1.82 Aug 16, 2019: Edwards SAPIEN 3 TAVR receives FDA approval for Low-Risk Patients 500

18.1.83 Aug 12, 2019: Stryker announces commercial structure realignment 501

18.1.84 Aug 07, 2019: Mark A. Beck elected to Owens & Minor Board of Directors 501

18.1.85 Aug 07, 2019: Dean Scarborough and John Weiland to join Cardinal Health’s Board of Directors 502

18.1.86 Aug 05, 2019: SFA Therapeutics requests FDA orphan drug designation (ODD) for SFA001 for treatment of hepatocellular carcinoma (HCC) 503

18.1.87 Aug 05, 2019: Orthofix names Jon Serbousek to Succeed CEO 503

18.1.88 Jul 25, 2019: Owens & Minor expands Senior Leadership team to Accelerate Company Growth 504

18.1.89 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 505

18.1.90 Jul 24, 2019: AirXpanders announces board changes 505

18.1.91 Jul 22, 2019: Adynxx adds Gregory J. Flesher to board of directors, completes up-listing to OTCQB market 506

18.1.92 Jul 22, 2019: Tactile Medical appoints Jay Stracke as Vice President of Reimbursement and Payer Relations 506

18.1.93 Jul 22, 2019: Owens & Minor names Mark Zacur as SVP, Chief Procurement Officer 507

18.1.94 Jul 16, 2019: BioDerm’s President Gaet Tyranski to assume President and Chief Executive Officer Responsibilities 507

18.1.95 Jul 16, 2019: Cardinal Health appoints Stephen Mason to lead medical segment 508

18.2 Financial Announcements 508

18.2.1 May 06, 2020: Abeona Therapeutics reports first quarter financial results and business updates 508

18.2.2 May 06, 2020: Harpoon Therapeutics reports first quarter 2020 financial results and provides corporate update 509

18.2.3 May 01, 2020: Hillrom’s fiscal second quarter financial results exceed guidance 510

18.2.4 Mar 16, 2020: Abeona Therapeutics reports fourth quarter and full year 2019 financial results and business updates 513

18.2.5 Mar 12, 2020: Lineage Cell Therapeutics reports fourth quarter and full year 2019 financial results and provides business update 513

18.2.6 Mar 09, 2020: Organogenesis Holdings reports fourth quarter and fiscal year 2019 financial results; Introduces fiscal year 2020 revenue guidance 516

18.2.7 Mar 03, 2020: GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ) Phase III trials at the 46th annual meeting of NANOS 519

18.2.8 Feb 28, 2020: Lattice Biologics reports Q1 2020 results 521

18.2.9 Feb 27, 2020: Collegium reports full-year 2019 revenue of $296.7 million 522

18.2.10 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 523

18.2.11 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance 524

18.2.12 Feb 14, 2020: Sonoma Pharmaceuticals reports third quarter FY 2020 financial results 525

18.2.13 Feb 13, 2020: CryoLife reports fourth quarter and full year 2019 financial results 526

18.2.14 Feb 10, 2020: Invacare announces financial results for the fourth quarter and full year ended December 31, 2019 527

18.2.15 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020 529

18.2.16 Feb 04, 2020: McKesson reports fiscal 2020 third quarter results 530

18.2.17 Jan 29, 2020: Avery Dennison announces fourth quarter and full year 2019 results 531

18.2.18 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook 532

18.2.19 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results 533

18.2.20 Jan 17, 2020: Scandinavian ChemoTech receives its first order from their new distributor in India 534

18.2.21 Jan 15, 2020: SomaLogic adds three new SomaSignal tests to its current offerings 535

18.2.22 Jan 13, 2020: Organogenesis Holdings reports preliminary revenue results for the fourth quarter and fiscal year 2019 536

18.2.23 Jan 13, 2020: Emergent BioSolutions announces preliminary 2019 financial results and provides 2020 financial forecast 537

18.2.24 Jan 13, 2020: Misonix reports preliminary fiscal 2020 second quarter revenue of approximately $19.7 million 538

18.2.25 Jan 13, 2020: Tactile Systems Technology reports preliminary full year and fourth quarter 2019 revenue results 539

18.2.26 Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance 540

18.2.27 Dec 31, 2019: Belgium customers select C-RAD’s innovative SIGRT solution 541

18.2.28 Dec 19, 2019: REDBUD LABS STR microfluidic chip enables 1000x faster sample prep for on-cartridge magnetic bead assay 542

18.2.29 Dec 18, 2019: Terason partners with AmCad BioMed to provide more efficient solutions to assess and diagnose obstructive sleep apnea 543

18.2.30 Dec 05, 2019: Epic Sciences to present new data showing feasibility of its liquid biopsy test in breast cancer 545

18.2.31 Dec 01, 2019: Hyland Healthcare launches new products and updates at RSNA 2019 547

18.2.32 Nov 20, 2019: UM trial to study new Stent that treated life-threatening brain aneurysm 549

18.2.33 Nov 19, 2019: ThermoGenesis Holdings announces improved third quarter 2019 financial results and provides corporate update 551

18.2.34 Nov 18, 2019: Sintx technologies releases 2019 third quarter and year to date earnings report and provides business update 553

18.2.35 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 553

18.2.36 Nov 14, 2019: Sonoma Pharmaceuticals reports second quarter FY 2020 financial results 555

18.2.37 Nov 13, 2019: AdaptHealth Corp. announces third quarter 2019 financial results for its AdaptHealth Holdings LLC subsidiary 556

18.2.38 Nov 12, 2019: Biostage reports third quarter 2019 financial results 557

18.2.39 Nov 12, 2019: Lineage Cell Therapeutics reports third quarter 2019 financial results and provides business update 558

18.2.40 Nov 12, 2019: Abeona Therapeutics reports third quarter 2019 financial results and business updates 560

18.2.41 Nov 12, 2019: PolarityTE reports third calendar quarter 2019 results 561

18.2.42 Nov 12, 2019: Organogenesis Holdings reports third quarter and nine months of 2019 financial results 562

18.2.43 Nov 12, 2019: Dynatronics reports first quarter results for fiscal 2020 565

18.2.44 Nov 08, 2019: Orgenesis third quarter 2019 revenue increases 46% to a record $9.1 Million 565

18.2.45 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020 566

18.2.46 Nov 07, 2019: InnerWorkings reports Q3 2019 financial results 567

18.2.47 Nov 07, 2019: NovaBay Pharmaceuticals reports 2019 third quarter financial results 567

18.2.48 Nov 07, 2019: Xtant Medical announces third quarter 2019 financial results 568

18.2.49 Nov 06, 2019: Scandit integrates with Epic Rover to enable accurate native iOS camera scanning in healthcare 569

18.2.50 Nov 06, 2019: Owens & Minor reports 3rd quarter 2019 financial results 570

18.2.51 Nov 06, 2019: Invacare reports results for third quarter 2019 570

18.2.52 Nov 06, 2019: Collegium reports third quarter 2019 financial results 572

18.2.53 Nov 06, 2019: Emergent BioSolutions reports financial results for third quarter and nine months ended September 30, 2019 573

18.2.54 Nov 06, 2019: Harpoon Therapeutics reports third quarter 2019 financial results and provides corporate update 575

18.2.55 Nov 05, 2019: Luna Innovations reports strong third-quarter 2019 results 576

18.2.56 Nov 04, 2019: Tactile Systems Technology reports third quarter 2019 financial results; updates 2019 outlook 577

18.2.57 Oct 30, 2019: Cue Biopharma announces upcoming scientific presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting 579

18.2.58 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 581

18.2.59 Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran 582

18.2.60 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 583

18.2.61 Oct 30, 2019: CONMED announces third quarter 2019 financial results 583

18.2.62 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 584

18.2.63 Oct 28, 2019: Orthofix reports third quarter 2019 results 586

18.2.64 Oct 24, 2019: Integra LifeSciences reports third quarter 2019 financial results 587

18.2.65 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 587

18.2.66 Oct 24, 2019: Anika reports third quarter 2019 financial results 589

18.2.67 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 590

18.2.68 Sep 28, 2019: GRAIL to present new data in late-breaking oral presentation at the European Society for Medical Oncology (ESMO) 2019 Congress 591

18.2.69 Sep 28, 2019: Orchestra BioMed announces late-breaking clinical results showing BackBeat Cardiac Neuromodulation Therapy drives significant reduction in systolic blood pressure 593

18.2.70 Sep 25, 2019: Dynatronics reports fourth quarter and full year results for fiscal 2019 595

18.2.71 Sep 19, 2019: Tresiba showed an overall lower risk of Hypoglycaemia and significantly lower HbA1c when compared to Insulin Glargine U300 in people with Type 2 Diabetes 596

18.2.72 Aug 29, 2019: Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019 597

18.2.73 Aug 29, 2019: Lattice Biologics reports third quarter 2019 results 598

18.2.74 Aug 28, 2019: Approval for the additional formulation of Samsca OD tablets in Japan 599

18.2.75 Aug 27, 2019: Gold nanoparticles shown to be safe and effective treatment for prostate cancer 600

18.2.76 Aug 21, 2019: aap receives US-American clearance (FDA) for polyaxial LOQTEQ VA calcaneus system; market launch planned for beginning of 2020 602

18.2.77 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 603

18.2.78 Aug 14, 2019: Coloplast delivers 8% organic growth and solid performance across all business areas 604

18.2.79 Aug 14, 2019: Coloplast announcement no. 07/2019 – 9M interim financial report, 2018/19 605

18.2.80 Aug 14, 2019: Misonix reports fourth quarter and fiscal year 2019 results 605

18.2.81 Aug 13, 2019: Biostage reports second quarter 2019 financial results 607

18.2.82 Aug 13, 2019: Cesca Therapeutics announces improved second quarter 2019 financial results and provides corporate update 608

18.2.83 Aug 13, 2019: Sonoma pharmaceuticals reports first quarter FY 2020 financial results 609

18.2.84 Aug 12, 2019: Applied Therapeutics reports second quarter 2019 financial results 610

18.2.85 Aug 12, 2019: Orgenesis second quarter 2019 revenue increases 95% to a record $7.8 Million 611

18.2.86 Aug 09, 2019: Abeona Therapeutics reports second quarter 2019 financial results and business updates 612

18.2.87 Aug 09, 2019: Organogenesis Holdings reports second quarter and first half 2019 financial results 612

18.2.88 Aug 08, 2019: Xtant Medical announces second quarter 2019 financial results 615

18.2.89 Aug 08, 2019: NN releases Q2 2019 financial results 615

18.2.90 Aug 08, 2019: Cardinal Health reports fourth quarter and full year results for fiscal year 2019 616

18.2.91 Aug 08, 2019: PolarityTE reports second calendar quarter 2019 results 618

18.2.92 Aug 08, 2019: BioTime reports second quarter 2019 financial results and provides business update 619

18.2.93 Aug 07, 2019: Collegium reports second quarter 2019 financial results 621

18.2.94 Aug 07, 2019: Owens & Minor reports 2nd quarter 2019 financial results 623

18.2.95 Aug 07, 2019: NovaBay Pharmaceuticals reports 2019 second quarter financial results 624

18.2.96 Aug 05, 2019: Tactile Systems Technology reports second quarter 2019 financial results; updates 2019 outlook 625

18.2.97 Aug 05, 2019: Orthofix reports second quarter 2019 results 627

18.2.98 Aug 05, 2019: Harpoon Therapeutics reports second quarter 2019 financial results and provides corporate update 627

18.2.99 Aug 05, 2019: Invacare reports results for second quarter 2019 628

18.2.100 Aug 02, 2019: Hillrom reports fiscal third quarter financial results 631

18.2.101 Aug 01, 2019: KIYATEC Assay hits the mark in study to predict patient response to first line ovarian cancer drugs 632

18.2.102 Jul 31, 2019: CONMED announces second quarter 2019 financial results 633

18.2.103 Jul 30, 2019: CryoLife reports second quarter 2019 financial results 634

18.2.104 Jul 25, 2019: Baxter reports second-quarter 2019 results 634

18.2.105 Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019 636

18.2.106 Jul 25, 2019: Stryker reports second quarter 2019 operating results 638

18.2.107 Jul 24, 2019: Integra LifeSciences reports second quarter 2019 financial results 638

18.2.108 Jul 24, 2019: Anika reports second quarter 2019 financial results 639

18.2.109 Jul 22, 2019: Study investigates the ability of continuous noninvasive hemoglobin monitoring with Masimo SpHb to reflect acute hemodilution during incremental fluid administration 640

18.2.110 Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results 642

18.3 Government and Public Interest 643

18.3.1 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 643

18.3.2 Sep 16, 2019: NAWCO announces first Advanced Wound Care Certified (AWCC) Clinicians 643

18.3.3 Sep 05, 2019: Invacare provides business update at Baird Global Healthcare Conference 643

18.3.4 Jul 24, 2019: Using body heat to speed healing 644

18.3.5 Jul 19, 2019: Reclassification of surgical staplers 645

18.4 Legal And Regulatory 645

18.4.1 Apr 08, 2020: PolarityTE announces conclusion of SEC investigation 645

18.4.2 Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures 646

18.4.3 Jan 13, 2020: Cortexyme announces the initiation of an open-label extension study for the GAIN Trial of COR388 in Alzheimer’s disease 646

18.4.4 Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter 647

18.4.5 Dec 19, 2019: gel-e changes its name to Medcura 647

18.4.6 Dec 16, 2019: Bausch Health Resolves “Stock Drop” Litigation initially filed in October 2015 648

18.4.7 Dec 03, 2019: Ferris Mfg. Corp. is pleased to announce settlement with an unauthorized distributor of its medical products 648

18.4.8 Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International 649

18.4.9 Nov 26, 2019: MiMedx announces Securities and Exchange Commission Settlement 649

18.4.10 Nov 26, 2019: SEC charges biotech company and executives with accounting fraud 649

18.4.11 Nov 14, 2019: Agile Therapeutics announces FDA extension of Twirla NDA review period 650

18.4.12 Nov 06, 2019: Calmare Therapeutics has $842,000 judgment vacated by the U.S. Court Of Appeals for the second circuit 650

18.4.13 Nov 01, 2019: New innovations in technology could benefit veterans with PTSD 651

18.4.14 Oct 31, 2019: Cesca Therapeutics to change name and ticker symbol to reflect new strategic focus 652

18.4.15 Oct 30, 2019: SANUWAVE successfully completes extensive round of quality system and technical file audits 653

18.4.16 Oct 17, 2019: United Health products to move manufacturing to U.S. 653

18.4.17 Oct 08, 2019: Intralink-Spine receives ISO-13485 certification 654

18.4.18 Oct 08, 2019: United Health Products files defamation lawsuit against short sellers 654

18.4.19 Sep 30, 2019: Adocia announces receipt of USD

14.3 million payment from Eli Lilly following arbitration conclusion and the decision by mutual consent with Eli Lilly to conclude the civil case 655

18.4.20 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker 655

18.4.21 Sep 04, 2019: LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 in Cardinal Health to contact the firm 655

18.4.22 Aug 29, 2019: Won Industry receives warning letter from FDA 655

18.4.23 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly 656

18.4.24 Aug 12, 2019: Lineage Cell Therapeutics launches new corporate brand 657

18.4.25 Aug 12, 2019: Lead plaintiff deadline alert: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 In Cardinal Health to contact the firm 657

18.5 Other Significant Developments 658

18.5.1 Jul 10, 2020: NYU Langone Health expands ambulatory care network on Long Island 658

18.5.2 Jul 02, 2020: Osteopore signs initial U.S. distribution agreement 658

18.5.3 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education 659

18.5.4 Jun 24, 2020: Apria Healthcare celebrates 25 years of patient service and commitment to quality care 659

18.5.5 May 06, 2020: Markman Biologics will revolutionize the wound care domain 660

18.5.6 Apr 16, 2020: GEMCORE adapts wound dressing to help protect healthcare workers from friction injuries caused by personal protective equipment and donates 8,000 units 660

18.5.7 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19 661

18.5.8 Apr 02, 2020: Organovo Holdings founder calls on board of directors to accept stockholders’ opposition to the illogical merger with Tarveda Therapeutics 661

18.5.9 Mar 31, 2020: Aroa Biosurgery opens new pathway for advanced wound treatment amidst covid-19 disruption in the United States 662

18.5.10 Mar 11, 2020: AllStar Health Brands announces it has entered into a distribution agreement With MedPharma Invest (Berberex) for the sales & marketing of patented wound care hospital and specialty skin care products 662

18.5.11 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes 663

18.5.12 Feb 11, 2020: InfuSystem enters negative pressure wound therapy market 663

18.5.13 Jan 30, 2020: Hollister awarded National, ASCEND Agreements in Ostomy Products with Premier 663

18.5.14 Jan 27, 2020: Breg adds benefits and eligibility checks to Breg Vision software for orthopedic bracing programs 664

18.5.15 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030 664

18.5.16 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point 665

18.5.17 Jan 13, 2020: Journey Medical recaps 2019 Growth 665

18.5.18 Jan 07, 2020: Nuvo Pharmaceuticals announces repayment of bridge loan and entitlement to receive 2019 Vimovo U.S. Annual minimum royalty 666

18.5.19 Jan 07, 2020: Collegium provides 2020 Financial Guidance 666

18.5.20 Jan 02, 2020: Lineage Cell Therapeutics conducts sale of shares in oncocyte 667

18.5.21 Dec 23, 2019: Orgenesis announces receipt of the $6.6 million second milestone payment into Masthercell Global subsidiary 667

18.5.22 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax 668

18.5.23 Dec 20, 2019: United Health products issues progress report 668

18.5.24 Dec 12, 2019: McKesson selected by Department of Veterans Affairs as prime pharmaceutical provider 669

18.5.25 Dec 11, 2019: Innovation Hub provides funding to seven entrepreneurial teams 669

18.5.26 Nov 26, 2019: Kane Biotech engages Kilmer Lucas for cross-border Investor Relations 671

18.5.27 Nov 14, 2019: BioMarin announces cumulative additional height gain of

9.0 cm over 54 months versus natural history in children with Achondroplasia treated with Vosoritide in phase 2 study 672

18.5.28 Nov 04, 2019: Ernie Green Industries and Gilero announce business realignment 674

18.5.29 Oct 29, 2019: Dissolution of a wholly-owned subsidiary–Clearbridge Health USA 674

18.5.30 Oct 16, 2019: Orgenesis announces Co-Development Agreement with Accellix 674

18.5.31 Oct 14, 2019: UH Rainbow Babies & Children’s Hospital receives $3 million to establish Pediatric Disaster Care Center of Excellence 675

18.5.32 Oct 07, 2019: Misuse of Surgical Staplers Tops ECRI Institute’s 2020 Technology Hazards List 675

18.5.33 Sep 24, 2019: Axxess partners with Swift Medical to enhance wound care offerings and help home health clients thrive under PDGM 676

18.5.34 Sep 16, 2019: BIOLIFE4D modifies its regulation A+ (Mini-IPO) offering following significant scientific achievement 676

18.5.35 Sep 13, 2019: BioRestorative Therapies comments on recent promotional activity 677

18.5.36 Sep 11, 2019: Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percent 678

18.5.37 Sep 09, 2019: Cesca Therapeutics and ThermoGenesis announce major global distribution agreement for the company’s X-Series products 679

18.5.38 Sep 03, 2019: Abeona Therapeutics announces strategic review 679

18.5.39 Aug 21, 2019: Joerns Healthcare completes reorganization plans 680

18.5.40 Jul 29, 2019: SINTX Technologies provides business update 680

18.5.41 Jul 29, 2019: Innovation Pharmaceuticals provides corporate update highlighting clinical pipeline progress and business development activities 681

18.5.42 Jul 29, 2019: NovaBay Pharmaceuticals reports 2019 second quarter net sales of $1.8 million 682

18.5.43 Jul 26, 2019: Court confirms reorganization plan for Joerns Healthcare 683

18.6 Product News 683

18.6.1 Jun 17, 2020: Researchers develop microscopy technique for noninvasive evaluation of wound healing 683

18.6.2 Feb 18, 2020: InventHelp inventor develops salve for treatment of burns (NWO-318) 684

18.6.3 Jan 13, 2020: InventHelp inventor develops therapeutic device for feet 684

18.6.4 Dec 20, 2019: Karolinska Development´s portfolio company Umecrine Cognition announces Notice of Allowance from USPTO for a patent protecting lead compound golexanolone 684

18.6.5 Dec 02, 2019: NanoVibronix to present at two investor conferences in December 685

18.6.6 Nov 05, 2019: Scapa Healthcare announces proprietary release system design for adhesive patches and dressings 685

18.6.7 Nov 01, 2019: Living skin can now be 3D-printed with blood vessels included 685

18.6.8 Oct 07, 2019: Arch Therapeutics provides corporate update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY 686

18.6.9 Oct 04, 2019: MEI Pharma announces updated clinical data from ME-401 phase 1b study in patients with Indolent B-cell Malignancies 687

18.6.10 Oct 04, 2019: McKesson launches strategic planning solution for community-based oncology customers 688

18.6.11 Sep 16, 2019: TeVido BioDevices announces availability of TruPigment for use in restoring lost skin color 689

18.6.12 Aug 14, 2019: Dynatronics to attend The National by FCA 2019 689

18.6.13 Aug 06, 2019: Endomedix to present its innovative technology addressing the needs of warfighters at the upcoming Military Health System and Research Symposium 2019 annual meeting 689

18.6.14 Jul 31, 2019: Ethicon: International experts convene to respond to the critical state of surgical site infections in Asia Pacific 690

18.6.15 Jul 25, 2019: Soft micro-monitors keep tabs on oxygen in new tissues 690

18.7 Research And Development 691

18.7.1 Nov 15, 2019: Invent Medic launches Efemia bladder support in Norway together with the distributor Quintet 691

18.7.2 Oct 23, 2019: BioRestorative Therapies receives a second patent in Australia for its metabolic program 692

18.8 Strategy And Business Planning 693

18.8.1 Jul 01, 2020: RenovaCare launches R&D innovation center (Berlin) for organ & tissue regeneration 693

18.8.2 Apr 14, 2020: Groundbreaking coalition of industry leaders bring telehealth to wound care at no cost during coronavirus pandemic 694

18.8.3 Apr 08, 2020: Sharp Fluidics buys robotic port closure technology from neoSurgical 694

18.8.4 Mar 11, 2020: RenovaCare announces new corporate headquarters and laboratory facilities 695

18.8.5 Jan 28, 2020: BandGrip Hooks the surgical suites of Rush University Medical Center with its advanced wound closure technology 695

18.8.6 Jan 21, 2020: Quartz and Advocate Aurora Health announce plans to collaborate in Eastern Wisconsin 696

18.8.7 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience 696

18.8.8 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 697

18.8.9 Jan 09, 2020: Zai Lab and Novocure announce first patient enrolled in a phase 2 pilot trial of tumor treating fields together with chemotherapy as first-line treatment of gastric cancer 698

18.8.10 Dec 13, 2019: 3M to divest drug delivery business to Altaris Capital in $650m deal 698

18.8.11 Dec 11, 2019: Amneal Pharmaceuticals to buy majority stake in AvKARE for $340m 699

18.8.12 Dec 06, 2019: Gilero opens new design center in Southern California 699

18.8.13 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn 700

18.8.14 Nov 05, 2019: Floyd Health System and Atrium Health to join in strategic combination 700

18.8.15 Nov 04, 2019: Atrium Health and Wake Forest one step closer to creating unique and transformative Academic Healthcare System 700

18.8.16 Oct 31, 2019: Continued expansion of gel-e’s consumer products label 702

18.8.17 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 702

18.8.18 Oct 02, 2019: Hollister announces grand opening of new manufacturing facility in Kaunas, Lithuania 703

18.8.19 Aug 30, 2019: Brigham Health announces September opening of comprehensive care facility in Pembroke 703

18.8.20 Aug 01, 2019: SeaSpine announces the launch of the Shoreline RT Cervical Interbody Implant System, featuring Reef Topography 704

19 Appendix 705

19.1 Research Methodology 706

19.1.1 Coverage 706

19.1.2 Secondary Research 706

19.1.3 Primary Research 707

19.1.4 Market Modeling and Forecasting 708

19.1.5 Company Share Analysis 709

19.1.6 Distribution Share Analysis 710

19.1.7 Benchmarking 710

19.2 GlobalData Consulting 710

19.3 Contact Us 711

19.4 Disclaimer 711

Frequently asked questions

United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others thematic reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others in real time.

  • Access a live United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.